Vivo Capital »

Pasithea Therapeutics Corp shares owned by Vivo Capital

Quarter-by-quarter ownership of Pasithea Therapeutics Corp (KTTA) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Pasithea Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Pasithea Therapeutics Corp held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pasithea Therapeutics Corp by Vivo Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6M 2.1M 0.74
2025-12-31 $2.7M 2.1M 1.29

More positions owned by Vivo Capital

Erasca Common (ERAS)
Praxis Precision Medicines Common (PRAX)
Terns Pharmaceuticals Common (TERN)
Trevi Therapeutics Common (TRVI)
DBV Technologies SA Sponsored Ads (DBVT)
Compass Therapeutics Common (CMPX)
Tango Therapeutics Common (TNGX)
SAB Biotherapeutics Common (SABS)
Corvus Pharmaceuticals Holdings Common (CRVS)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Dianthus Therapeutics Common (DNTH)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
Minerva Neurosciences Common (NERV)

View all positions for Vivo Capital

Top funds holding Pasithea Therapeutics Corp

Squadron Capital Management
Adage Capital Partners GP
Vivo Capital
Henderson Group
Ameriprise Financial
Cable Car Capital
AdvisorShares Investments
Persistent Asset Partners
Stonepine Capital Management
Geode Capital Management
Vanguard Group
Vanguard Capital Management
Vanguard Fiduciary Trust
Northern Trust
UBS Group

View all funds holding Pasithea Therapeutics Corp